Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BRO
BRO logo

BRO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Brown & Brown Inc (BRO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
68.380
1 Day change
-0.29%
52 Week Range
125.670
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Brown & Brown Inc (BRO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong revenue and net income growth in its latest quarter, the lack of immediate positive catalysts, cautious sentiment from Congress trading data, and hedge fund selling suggest a wait-and-see approach is more prudent. Additionally, the stock's technical indicators and options data do not indicate a compelling entry point right now.

Technical Analysis

The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 73.798, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level (R1: 73.158), with limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest a bullish sentiment in the options market. However, the implied volatility percentile is high (94.42), indicating elevated uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • Analysts like Mizuho have recently upgraded the stock to 'Outperform' with a price target of $85, citing low disruption risks from AI in its market segment.

Neutral/Negative Catalysts

  • Congress members have been selling the stock, with no purchase transactions in the last 90 days. Hedge funds have also significantly increased their selling activity (up 415.35% last quarter). Analyst price targets have been revised downward by multiple firms, reflecting cautious sentiment. Additionally, the stock has an 80% chance of declining in the short term based on historical patterns.

Financial Performance

In Q4 2025, revenue increased by 35.84% YoY to $1.607 billion, and net income rose by 26.09% YoY to $261 million. However, EPS dropped by 15.28% YoY to $0.61, indicating potential margin pressures or dilution.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed on the stock. Mizuho upgraded it to 'Outperform' with a price target of $85, citing low disruption risks from AI. However, other firms like Morgan Stanley and Raymond James have lowered price targets, citing weak pricing and growth headwinds. The consensus sentiment appears cautiously optimistic but not overwhelmingly bullish.

Wall Street analysts forecast BRO stock price to rise
13 Analyst Rating
Wall Street analysts forecast BRO stock price to rise
1 Buy
12 Hold
0 Sell
Hold
Current: 68.580
sliders
Low
73
Averages
84.09
High
100
Current: 68.580
sliders
Low
73
Averages
84.09
High
100
Barclays
Alex Scott
Equal Weight
maintain
$82 -> $80
AI Analysis
2026-03-11
New
Reason
Barclays
Alex Scott
Price Target
$82 -> $80
AI Analysis
2026-03-11
New
maintain
Equal Weight
Reason
Barclays analyst Alex Scott lowered the firm's price target on Brown & Brown to $80 from $82 and keeps an Equal Weight rating on the shares. The insurance broker group has "derated sharply on fears of AI-driven disruption," the analyst tells investors in a research note. Barclays views the selloff as overdone and believes current share multiples now "more than discount" slower growth while overlooking durability of the broker business model and AI's potential to support productivity and margins. The analyst views AI as a "productivity enabler" for the brokers.
Mizuho
Neutral -> Outperform
upgrade
$84 -> $85
2026-02-27
Reason
Mizuho
Price Target
$84 -> $85
2026-02-27
upgrade
Neutral -> Outperform
Reason
Mizuho upgraded Brown & Brown to Outperform from Neutral with a price target of $85, up from $84. The firm adjusted ratings in the insurance property and casualty group following the recent sector selloff. There is "low disruption threat" to the insurance brokerage names who focus on middle-market and larger accounts from AI, the analyst tells investors in a research note. Mizuho believes disintermediation risk is "geared to mass market personal lines and the smaller end of SME."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BRO
Unlock Now

People Also Watch